Meddevicetracker: 医療機器の市場調査分析・データベース
Discover the top medtech stories from the last week below
By Chris Farrell 25 Sep 2017
Meddevicetracker weekly round up
11 Total results for product and free and sample content found
Meddevicetracker: 医療機器の市場調査分析・データベース
By Chris Farrell 25 Sep 2017
Meddevicetracker weekly round up
Topic Medtech weekly roundup
Medtech Insight: 世界の医療機器・医療技術の最新情報
By Tina Tan 18 Apr 2017
While the in vitro diagnostics landscape has seen players come and go, Roche Diagnostics has remained at the top. But the Swiss giant, like all its other smaller rivals, is facing a new reality, with increasing pressures to prove medical value, and a more stringent regulatory environment. Medtech Insight spoke to Roche Diagnostics' Jean-Claude Gottraux, head of centralized and point of care solutions, and Jean-Jacques Palombo, lifecycle leader for the company's cardiac, women's health and personalized health care solutions immunoassay portfolio, to gain their perspectives on how the sector has evolved and will continue to evolve. They also spoke about the company's strategy to address these changes and challenges.
Pink Sheet: 世界の薬事規制と承認審査に関するニュース
05 Apr 2017
Interviews with US payers suggest that at first they are more likely to focus on promoting biosimilars in treatment-naïve patients, as opposed to switching those on branded drugs, according to a new Datamonitor report.
Topic biosimilars
Pink Sheet: 世界の薬事規制と承認審査に関するニュース
By sten-stovall 05 Apr 2017
Biogen's chief medical officer says iPhone technology should in future be used for early warning diagnosis of Alzheimer's Disease.
Topic alzheimers
Pink Sheet: 世界の薬事規制と承認審査に関するニュース
By Derrick Gingery 31 Mar 2017
Amendment defunding Planned Parenthood is one ACA repeal refugee that could hitch a ride with user fee bill, which would be 'problematic,' to say the least, for Democrats.
Pink Sheet: 世界の薬事規制と承認審査に関するニュース
17 Jan 2017
Congressional oversight agency urges FDA to make better use of foreign offices with more effective performance measures and staffing goals; GAO notes agency’s progress towards risk-based inspections – and its plan to revisit every site at least once every five years.
Scrip: 世界の医療用医薬品＆製薬産業に関するニュース
11 Oct 2016
Lilly’s solanezumab, Roche/Genentech’s Ocrevus and Cempra’s solithromycin are among the key therapies scheduled for major data read-outs or approval decisions in Q4 2016.
Medtech Insight: 世界の医療機器・医療技術の最新情報
By Amanda Maxwell 10 Oct 2016
Medtech regulatory service providers cannot afford to "wait and see" on the final outcome of Brexit. Questions such as the appropriate base of operations to serve device companies looking to
Topic brexit
Scrip: 世界の医療用医薬品＆製薬産業に関するニュース
By Jessica Merril 10 Oct 2016
Merck’s strong Phase II data testing Keytruda with chemotherapy
Topic immuno-oncology
No Records Found
製品説明＆デモお申込
専任スタッフによるデモンストレーションを兼ねたサービスの詳しいご説明、または無料トライアルを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。
＊一部のサービスでは無料トライアルをご利用になれません。
お問い合わせ先
ご質問等ございましたらお気軽にご連絡下さい。
日本（平日：9時～18時）
電話：+81 (0)3 6273 4260
Email：inquiry.jp@informa.com
レポートストア
オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。
お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。